Coronavirus digest: BioNTech/Pfizer submit children's vaccine trial data

The BioNTech/Pfizer vaccine for 5 to 11 year olds could be approved in the US as early as October. Meanwhile, Australia plans to stop paying workers affected by lockdowns. Follow DW for the latest.